The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global nucleic acid isolation and purification market size reached US$ 4.45 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.47 Billion by 2027, exhibiting a growth rate (CAGR) of 8.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Nucleic acid isolation and purification are routine procedures in molecular biology and forensic analysis. They are used for separating deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from proteins, membranes, and other cellular materials through reagent-based and column-based techniques. Hair, blood, bones, sperm, saliva, nails, and urine are some of the commonly used sources for nucleic acid isolation and purification. They assist clinicians in processing the samples in minimum time, diagnosing patients with genetic mutations, determining the high risk for cancer, developing new therapeutics, and enhancing the effectiveness of drugs. As a result, these techniques are extensively employed in various verticals, including bioscience research, gene-splicing, molecular diagnostics, pharmaceuticals, and forensics.
The increasing employment of the procedure in pharmaceutical and biotechnological industries across the globe represents one of the key factors driving the market growth. Nucleic acid isolation and purification are used to identify microorganisms and genetic predispositions, detect different mutations, and determine their role in antibiotics. In line with this, the increasing prevalence of infectious diseases, genetic disorders, and chronic conditions, such as cancer, are favoring the market growth. Apart from this, the introduction of magnetic bead-based extraction kits used for liquid handling platforms that are capable of extracting the highest purity nucleic acids from tissue, blood, and plant materials is providing an impetus to the market growth. Furthermore, the rising awareness about genomic diagnostics among patients and the increasing efficiency of genomics sequencing in diagnosing diseases is acting as another growth-inducing factor. Additionally, the widespread utilization of DNA and RNA isolation for screening and detecting pathogens and microorganisms in routine samples and the rapid adoption of polymerase chain reaction (PCR) techniques to detect genetic abnormalities are supporting the market growth. Other factors, including the significant improvements in the healthcare infrastructure and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleic acid isolation and purification market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, type, method and end user.
Breakup by Product:
Breakup by Type:
Breakup by Method:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., Macherey-Nagel Gmbh & Co. Kg, New England Biolabs, Norgen Biotek Corp., Omega Bio-Tek Inc., Promega Corporation, Qiagen, Roche Molecular Systems Inc. (F. Hoffmann-La Roche AG), Takara Bio Inc. (Takara Holdings Inc.) and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Type, Method, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., Macherey-Nagel Gmbh & Co. Kg, New England Biolabs, Norgen Biotek Corp., Omega Bio-Tek Inc., Promega Corporation, Qiagen, Roche Molecular Systems Inc. (F. Hoffmann-La Roche AG), Takara Bio Inc. (Takara Holdings Inc.) and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at